Table 1 Demographics of the clinical features, comorbidities and physical characteristics in the study population
| Â | Total | Men | Women |
|---|---|---|---|
n = 2077 | n = 730 | n = 1347 | |
Age, y | 68.3 (5.4) | 69.5 (5.4) | 67.7 (5.3) |
BMI, kg/m2 | 22.4 (3.0) | 23.0 (2.8) | 22.0 (3.1) |
GLFS-25 score, /total of 120 | 7.3 (9.2) | 6.7 (8.4) | 7.6 (9.6) |
Prevalence of LS stage 1, n (%) | 507 (24.4%) | 161 (22.1%) | 346 (25.7%) |
stage 2, n (%) | 115 (5.5%) | 46 (6.3%) | 69 (5.1%) |
stage 3, n (%) | 136 (6.5%) | 39 (5.3%) | 97 (7.2%) |
Sarcopenia, n (%) | 111 (5.3%) | 49 (6.7%) | 62 (4.6%) |
Osteoporosis, n (%) | 305 (14.7%) | 10 (1.4%) | 295 (21.9%) |
Diabetes mellitus, n (%) | 232 (11.2%) | 119 (16.3%) | 113 (8.4%) |
LBP, n (%) | 1133 (54.5%) | 403 (55.2%) | 730 (54.2%) |
Knee pain, n (%) | 802 (38.6%) | 294 (40.3%) | 508 (37.7%) |
SMI, kg/m2 | 6.63 (0.94) | 7.57 (0.68) | 6.13 (0.60) |
ECW/ICW ratio, a.u | 4.74 (0.66) | 4.28 (0.53) | 4.99 (0.58) |
Usual gait speed, m/s | 1.30 (0.18) | 1.32 (0.17) | 1.27 (0.19) |
Five-times chair-stand, s | 8.68 (2.59) | 8.47 (2.37) | 9.07 (2.92) |
Single-leg standing, s | 44.29 (20.02) | 45.94 (19.19) | 41.24 (21.13) |
SPPB, /total of 12 | 11.72 (0.71) | 11.78 (0.60) | 11.61 (0.86) |
Grip power, kg | 28.35 (8.75) | 37.92 (6.82) | 23.16 (4.04) |
Knee extension strength, Nm | 116.64 (50.19) | 159.35 (53.04) | 93.50 (28.90) |
Hip flexion strength, Nm | 41.98 (15.65) | 53.28 (17.62) | 35.86 (10.14) |
Hip abduction strength, Nm | 24.29 (7.89) | 30.48 (7.82) | 20.94 (5.55) |